Doma E, Mayer I, Brandstoetter T, Maurer B, Grausenburger R, Menzl I
Blood Adv. 2021; 5(1):39-53.
PMID: 33570624
PMC: 7805318.
DOI: 10.1182/bloodadvances.2020003022.
Ditsiou A, Cilibrasi C, Simigdala N, Papakyriakou A, Milton-Harris L, Vella V
Sci Adv. 2020; 6(46).
PMID: 33188023
PMC: 7673765.
DOI: 10.1126/sciadv.abc3099.
Dong L, Reljic B, Cheung J, Ng E, Lindqvist L, Elefanty A
Cell Death Differ. 2019; 26(10):2074-2085.
PMID: 30770875
PMC: 6748108.
DOI: 10.1038/s41418-019-0275-z.
Kizilors A, Pickard M, Schulte C, Yacqub-Usman K, McCarthy N, Gan S
Biosci Rep. 2017; 37(4).
PMID: 28754805
PMC: 5634340.
DOI: 10.1042/BSR20170843.
Behrens K, Maul K, Tekin N, Kriebitzsch N, Indenbirken D, Prassolov V
J Exp Med. 2017; 214(3):737-752.
PMID: 28213513
PMC: 5339673.
DOI: 10.1084/jem.20160927.
A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia.
Woessner D, Eiring A, Bruno B, Zabriskie M, Reynolds K, Miller G
Leukemia. 2015; 29(8):1668-75.
PMID: 25721898
PMC: 4621806.
DOI: 10.1038/leu.2015.53.
Differences in growth promotion, drug response and intracellular protein trafficking of FLT3 mutants.
Mashkani B, Griffith R, Ashman L
Iran J Basic Med Sci. 2015; 17(11):867-73.
PMID: 25691928
PMC: 4328095.
CIN85 interacting proteins in B cells-specific role for SHIP-1.
Buchse T, Horras N, Lenfert E, Krystal G, Korbel S, Schumann M
Mol Cell Proteomics. 2011; 10(10):M110.006239.
PMID: 21725061
PMC: 3205855.
DOI: 10.1074/mcp.M110.006239.
Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection.
Uyttenhove C, Marillier R, Tacchini-Cottier F, Charmoy M, Caspi R, Damsker J
J Leukoc Biol. 2011; 89(6):1001-7.
PMID: 21385949
PMC: 3157325.
DOI: 10.1189/jlb.1210699.
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers.
Roberts K, Smith A, McDougall F, Carpenter H, Horan M, Neviani P
Cancer Res. 2010; 70(13):5438-47.
PMID: 20551067
PMC: 2933456.
DOI: 10.1158/0008-5472.CAN-09-2544.
Crossing paths: interactions between the cell death machinery and growth factor survival signals.
Brumatti G, Salmanidis M, Ekert P
Cell Mol Life Sci. 2010; 67(10):1619-30.
PMID: 20157838
PMC: 11115775.
DOI: 10.1007/s00018-010-0288-8.
Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo.
Sadowski M, Pankiewicz J, Prelli F, Scholtzova H, Spinner D, Kascsak R
Neurobiol Dis. 2009; 34(2):267-78.
PMID: 19385058
PMC: 2713020.
DOI: 10.1016/j.nbd.2009.01.013.
The outcome of phagocytic cell division with infectious cargo depends on single phagosome formation.
Luo Y, Alvarez M, Xia L, Casadevall A
PLoS One. 2008; 3(9):e3219.
PMID: 18795151
PMC: 2535564.
DOI: 10.1371/journal.pone.0003219.
Isolation of genes controlling apoptosis through their effects on cell survival.
Williams G, Hughes J, Stoneman V, Anderson C, McCarthy N, Mourtada-Maarabouni M
Gene Ther Mol Biol. 2007; 10(B):255-262.
PMID: 17372619
PMC: 1828370.
Solubility and bioactivity of the Pseudomonas quinolone signal are increased by a Pseudomonas aeruginosa-produced surfactant.
Calfee M, Shelton J, McCubrey J, Pesci E
Infect Immun. 2005; 73(2):878-82.
PMID: 15664929
PMC: 547021.
DOI: 10.1128/IAI.73.2.878-882.2005.
Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb.
Kumar A, Baker S, Lee C, Reddy E
Mol Cell Biol. 2003; 23(18):6631-45.
PMID: 12944488
PMC: 193713.
DOI: 10.1128/MCB.23.18.6631-6645.2003.
Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors.
Lee A, States D
Mol Cell Biol. 2000; 20(18):6779-98.
PMID: 10958675
PMC: 86204.
DOI: 10.1128/MCB.20.18.6779-6798.2000.
The mouse mammary tumor virus transcription enhancers for hematopoietic progenitor and mammary gland cells share functional elements.
Reuss F, Coffin J
J Virol. 2000; 74(17):8183-7.
PMID: 10933730
PMC: 112353.
DOI: 10.1128/jvi.74.17.8183-8187.2000.
Oligomerization and scaffolding functions of the erythropoietin receptor cytoplasmic tail.
Watowich S, Liu K, Xie X, Lai S, Mikami A, Longmore G
J Biol Chem. 1999; 274(9):5415-21.
PMID: 10026152
PMC: 2388248.
DOI: 10.1074/jbc.274.9.5415.
Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b.
Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg A, Sauvageau G
EMBO J. 1998; 17(13):3714-25.
PMID: 9649441
PMC: 1170707.
DOI: 10.1093/emboj/17.13.3714.